Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A0A3Q8ICW2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 105 | 107 | PF00675 | 0.600 |
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.696 |
CLV_PCSK_KEX2_1 | 104 | 106 | PF00082 | 0.620 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.696 |
CLV_PCSK_KEX2_1 | 26 | 28 | PF00082 | 0.614 |
CLV_PCSK_PC1ET2_1 | 104 | 106 | PF00082 | 0.425 |
CLV_PCSK_PC1ET2_1 | 26 | 28 | PF00082 | 0.614 |
CLV_PCSK_PC7_1 | 100 | 106 | PF00082 | 0.408 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.516 |
DEG_APCC_DBOX_1 | 104 | 112 | PF00400 | 0.608 |
DOC_MAPK_gen_1 | 104 | 114 | PF00069 | 0.483 |
DOC_MAPK_gen_1 | 26 | 33 | PF00069 | 0.626 |
DOC_MAPK_MEF2A_6 | 77 | 85 | PF00069 | 0.571 |
DOC_WW_Pin1_4 | 133 | 138 | PF00397 | 0.628 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.529 |
LIG_14-3-3_CanoR_1 | 14 | 24 | PF00244 | 0.518 |
LIG_14-3-3_CanoR_1 | 46 | 52 | PF00244 | 0.520 |
LIG_Actin_WH2_2 | 42 | 59 | PF00022 | 0.561 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.672 |
LIG_eIF4E_1 | 102 | 108 | PF01652 | 0.609 |
LIG_eIF4E_1 | 138 | 144 | PF01652 | 0.539 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.472 |
LIG_FHA_2 | 93 | 99 | PF00498 | 0.471 |
LIG_LIR_Nem_3 | 10 | 16 | PF02991 | 0.525 |
LIG_MYND_1 | 161 | 165 | PF01753 | 0.542 |
LIG_Pex14_1 | 29 | 33 | PF04695 | 0.490 |
LIG_Pex14_2 | 114 | 118 | PF04695 | 0.481 |
LIG_SH2_STAP1 | 52 | 56 | PF00017 | 0.583 |
LIG_SH2_STAT3 | 166 | 169 | PF00017 | 0.538 |
LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.463 |
LIG_SH3_3 | 150 | 156 | PF00018 | 0.456 |
LIG_SH3_3 | 78 | 84 | PF00018 | 0.555 |
LIG_SUMO_SIM_par_1 | 57 | 62 | PF11976 | 0.522 |
LIG_WRPW_2 | 13 | 16 | PF00400 | 0.513 |
MOD_CK1_1 | 136 | 142 | PF00069 | 0.528 |
MOD_CK2_1 | 136 | 142 | PF00069 | 0.648 |
MOD_CK2_1 | 17 | 23 | PF00069 | 0.469 |
MOD_CK2_1 | 66 | 72 | PF00069 | 0.529 |
MOD_DYRK1A_RPxSP_1 | 77 | 81 | PF00069 | 0.412 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.527 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.544 |
MOD_NEK2_1 | 92 | 97 | PF00069 | 0.454 |
MOD_PIKK_1 | 34 | 40 | PF00454 | 0.603 |
MOD_Plk_2-3 | 98 | 104 | PF00069 | 0.535 |
MOD_Plk_4 | 47 | 53 | PF00069 | 0.526 |
MOD_ProDKin_1 | 133 | 139 | PF00069 | 0.628 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.531 |
TRG_DiLeu_BaEn_1 | 103 | 108 | PF01217 | 0.635 |
TRG_DiLeu_BaLyEn_6 | 81 | 86 | PF01217 | 0.474 |
TRG_DiLeu_LyEn_5 | 103 | 108 | PF01217 | 0.610 |
TRG_ENDOCYTIC_2 | 28 | 31 | PF00928 | 0.489 |
TRG_ER_diArg_1 | 105 | 107 | PF00400 | 0.600 |
TRG_ER_diArg_1 | 144 | 147 | PF00400 | 0.528 |
TRG_ER_diArg_1 | 166 | 168 | PF00400 | 0.552 |
TRG_Pf-PMV_PEXEL_1 | 105 | 110 | PF00026 | 0.606 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I5S9 | Leptomonas seymouri | 81% | 100% |
A0A0S4II66 | Bodo saltans | 50% | 99% |
A0A1X0NSB7 | Trypanosomatidae | 60% | 96% |
A0A3R7M837 | Trypanosoma rangeli | 62% | 99% |
A4HEU7 | Leishmania braziliensis | 93% | 100% |
A4I221 | Leishmania infantum | 100% | 100% |
C9ZRY6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 100% |
E9AY70 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4Q9A2 | Leishmania major | 95% | 100% |
V5DR82 | Trypanosoma cruzi | 60% | 100% |